Weight loss and diabetes may just be the beginning for drugs like Ozempic, Wegovy, Mounjaro and Zepbound as reports increasingly suggest they may have far-reaching benefits for treating conditions as diverse as heart disease, liver disease, Parkinson’s, sleep apnea and addiction, sparking research among firms competing in pharma’s latest gold rush.
